STREAMEX CORP. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STREAMEX CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-09-30 was $20.00K.
- STREAMEX CORP. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $218.00K, a 0.00% change from fiscal 2022.
- STREAMEX CORP. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $218.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $218.00K 10-K · filed 2024-04-16 | |
| 2022-12-31 | $218.00K 10-K · filed 2024-04-16 | |
| 2017-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |